Heart Drugs Show Promise for Fighting Colon Cancer

Jenny Felth, Joachim Gullbo, and colleagues note that cardiac glycosides are a family of naturally-derived drugs used to treat congestive heart failure and abnormal heart rhythms. Scientists have suspected for some time, based on previous research, that these heart drugs may have promise for fighting many different types of cancer. Despite this, knowledge on effects in colon cancer or combination effects with other anti-cancer drugs is lacking. But scientists know little about their potential anticancer effects and have not tested these substances against colon cancer.

As part of a larger study to screen and identify natural substances with activity against colon cancer, the scientists picked several cardiac glycosides for further study. They tested five of these heart drugs against laboratory cultures of human colon cancer cells and found that they were all effective, to varying degrees, at killing the cancer cells.

» Read more: Heart Drugs Show Promise for Fighting Colon Cancer

Related posts

The Institute Of Cancer Research Receives Environmental Honour

The Institute Of Cancer Research Receives Environmental Honour
The Institute of Cancer Research (ICR) is pleased to announce that it will be presented with the EcoCampus Bronze Certificate on 3rd February in recognition of its commitment to improve environmental sustainability. EcoCampus is a scheme designed to encourage and provide tools to assist higher educational institutions in creating and maintaining good environmental and management practices. The …

Read more on Medical News Today

Related posts

Competitive Technologies’ Calmare(R) Therapy Medical Device Treating Cancer Patients In Virginia

Competitive Technologies’ Calmare(R) Therapy Medical Device Treating Cancer Patients In Virginia
Competitive Technologies, Inc. announced that a premier physician oncology practice based in Virginia has begun using CTT’s Calmare® Therapy pain therapy medical device to treat patients suffering from pain related to cancer, under the direction of several medical oncologists.

Read more on News-Medical-Net

Related posts